All
  • All
  • ELISA Kit
  • Protein
  • Antibody
  • Molecular Biology Product
  • Small Molecule
All
  • All
  • ELISA Kit
  • Protein
  • Antibody
  • Molecular Biology Product
  • Small Molecule

Recombinant Lithobates catesbeiana Androgen receptor (ar), partial

Code
MSDS
MSDS Datasheet
Size Pls inquire
Source
Conjugate
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Abbreviation
ar
Purity
>85% (SDS-PAGE)
Target Names
ar
Uniprot NO.
Species
Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)
Source
Yeast
Expression Region
1-777
Target Protein Sequence
MEVHIGLGGV YKQPPGKMIR GAFENLFLSV REALQGERRS AASLDTSSPI SACVHPHPTW NEPSTWTEVR GTPWREPQGA QPDPPPCSPR SQAPQFTLSS CTTELKEILG EQGGMPEEGN SESASKEGYP ESISDSAKEI CKAVSVSLGL SMEALEHLSA AGEWQRGDCM FAGPPHHTMG AQTCQVAEED KSDTSFSQYR EGAFRRAGQS TYSAGKAPED GSSLPTEDKE QPCTDMALSE PGSLRSRGME VMPSLTLYKP TAFMEDASAY PGRDYYSFQM ALAPHGRIKV ESPIEFAGSA WGGPSRYSEF PGFSHCGPSA NWHSLFEEGQ ATASYTDSSL YSYPRSHVPA GPDGEFSAEA WYPATAMLGR VHMAVPMRPR MTHGWTATLG IRRRLGWTGV ESTFYPIDYY FPPQKPCLSC EDEASGCHYE ALTCGSCKVF FKRAAEGNQK YLCASRNDCT IDKFRRKNCP SCRLRKCYEA GMTLGARKLK KLGNLKAQEE LEGSPGQSEG REMPPNMSIP QLEGYSCQPI FLNVLEAIEP MVVCSGHDNN QPDSFALLLS SLNELGERQL VHVVKWAKAL PGFRNLHVND QMTVIQYSWM GLMIFAMGWR SFKNVNSRML YFAPDLVFNE YRMHKSRMYS QCVRMRHLSQ EFGWLQVTPE EFLCDEGPSA LSIIPVEGLK DQKCFDELRM NYIKELDRVI SCKRNNPASS SPRFFNLPKL LGSVQPIDVN LVQFTFGLFG KAQMVSVDFP EMMSEIISVQ VPKILSGRVK PLYFHSS
Note: The complete sequence may include tag sequence, target protein sequence, linker sequence and extra sequence that is translated with the protein sequence for the purpose(s) of secretion, stability, solubility, etc.
If the exact amino acid sequence of this recombinant protein is critical to your application, please explicitly request the full and complete sequence of this protein before ordering.
Protein Length
Partial
Tag Info
N-terminal His-tagged/Tag-Free
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Storage
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

Related Products

Customer Reviews and Q&A

■ Customer Reviews

Submit a Review here

Target Background

Function(From Uniprot)
Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins.
Subcellular Location
Nucleus. Cytoplasm.
Protein Families
Nuclear hormone receptor family, NR3 subfamily
Tissue Specificity
Detected in somatic Leydig and Sertoli cells in testis with high level expression. Also detected at lower expression levels in forebrain and heart.
Promotions
Reward For Reviews
Free trial size antibodies
Contact Us

  Email: support@cusabio.com
  Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Related Articles
Client Literature Review IF=52.7: Targeting SKAP2 Restores Sperm Motility and Morphology by Regulating Mitochondrial Organization and Cytoskeletal RemodelingANGPTL3: From Mechanisms to Clinics, Exploring a Novel Therapeutic Target for Cardiometabolic DiseasesAcross Borders, Built on Trust. CUSABIO 2025 Year-in-ReviewACVR1C/ALK7: An Emerging Target in Metabolic Diseases and Cancer Therapy2026 Trends in Macromolecular Drug Targets: GLP-1 Deepening, Cardiovascular Remodeling, Immune Combinations, and the "Post-PD-1" EraCRLF2 (TSLPR): A Key Target Linking Type 2 Inflammation to Hematologic MalignanciesPDGFRA: A Hub in Cellular Signaling and a Therapeutic TargetBTLA: An Emerging Target in Immunotherapy – New Insights into Cancer and Autoimmune DiseasesMacrophage Migration Inhibitory Factor (MIF): A Pleiotropic Target Linking Inflammation and CancerA Novel Target for Cancer Therapy: FAP – From Tumor Microenvironment Regulation to TheranosticsGPR20: From "Orphan" to a Promising Novel Target for Overcoming Drug-Resistant GISTIL1RAP: Background, Research Mechanisms, Signaling Pathways, Related Diseases, and Latest Advances in Drug DevelopmentTargeting EPHA2: An Emerging Focus in Combating Tumor Drug Resistance and MetastasisTargeting TNFRSF13B: Dual-Target Strategies Usher in New Focus for Treating Tumors and Autoimmune DiseasesSIGLEC15: An Emerging Immune Checkpoint Target in Tumor ImmunotherapyMetabolic Hub, Reprogramming Disease: SLC3A2 – From Amino Acid Transport Mechanism to Emerging Therapeutic TargetCD45: The Immune Cell "Gatekeeper" Protein – Why is it Emerging as a Novel Therapeutic Target?FLT1 (VEGFR-1): A Bidirectional Regulator of Angiogenesis and an Emerging Therapeutic TargetCUSABIO Quarterly Citation Review: 800 New Product Citations in Q3, Total Citations Hit 27,500!Nicotinic Acetylcholine Receptor α1 Subunit (CHRNA1): Structure, Functional Mechanisms, and Disease-Related Research ProgressSITC’s 40th Anniversary Annual MeetingSEZ6: A New Therapeutic Target for Neuroendocrine Tumors with Multiple ADCs in Clinical DevelopmentTargeting the "Hidden Target" ROR1: A Breakthrough for Broad-Spectrum Cancer Therapy?Parathyroid Hormone (PTH): A Key Target for Regulating Calcium-Phosphate Metabolism and Skeletal HealthTSLP: A Key Target in Allergic and Inflammatory DiseasesCUSABIO Quarterly Citation Review: 800 New Product Citations in Q2, Total Citations Hit 27,000!LYPD3: An Emerging Star in Solid Tumor TherapyMICA: key regulatory molecule for tumor immune surveillance and its therapeutic target potentialMICB: a key molecule that bridges cellular stress and immune responsesColony Stimulating Factor 1 (CSF1): Its Key Role in Diseases and New Progress in Targeted TherapyTargeting LRRC15: From tumor microenvironment regulation to fibrotic/infectious disease therapyPTH1R: Key Therapeutic Target in Bone & Metabolic Health | CUSABIOImmune Battlefield's "Scout": Decoding the NCR3 TargetHow Do CTLA4 Inhibitors Work? A Complete Guide for Early-Career ResearchersPioneering CAR-T Cell Therapy: Advancing Personalized Cancer TreatmentEDNRA: A Key Target for Disease-Associated Angioplasty, Tumor Invasion, and Metabolic RegulationDLL4: A Key Target for Angiogenesis RegulationCEACAM1: An Emerging Multifunctional Target for Cancer-Immune ModulationMSTN: A Key Target for Targeted Therapy in Muscle Diseases​PVR (CD155): A Key Factor in Tumor Immune Evasion and a Novel Therapeutic TargetTNFRSF13C (BAFF-R): A Key Target for Immune Regulation and Disease TreatmentHow AI is Reshaping Biological Research? A Comprehensive Guide to Tools and Practical StrategiesCUSABIO Quarterly Citation Review: 800 New Product Citations in the First Quarter, Total Citations Hit 26,000!CUSABIO Monthly Citation Review: 200 New Product Citations in February, Total Citations Hit 25,000!The Structure, Function, and Research Progress of Lymphotoxin β Receptor (LTBR) in Disease and Drug DevelopmentCD79A and CD79B: Key Targets in B Cell Signaling Pathways and Therapeutic PotentialCUSABIO Monthly Citation Review: 220 New Product Citations in January, Total Citations Reach 24,500!TNFSF15/TL1A: The Rise of the Next Billion-Dollar Target as Pharma Giants Stake Their ClaimsAdvancements in CDH6-Targeted Drug Research for Cancer TreatmentTIGIT Targeted Immunotherapies Offer New Hope for Cancer TreatmentCUSABIO Monthly Citations Review: November 2024, Over 230 Citations with an Impact Factor Exceeding 1200, Totaling 24,100 Articles!ACVR2A and ACVR2B as Key Targets for Muscle Growth, Weight Loss, PHA in Drug Research！What Is Compartment Modelling in Pharmacokinetics?CUSABIO Monthly Citations Review: October 2024, Over 240 Citations with an Impact Factor Exceeding 1200, Totaling 23,800 Articles!What Bacterial Antigens Are Used in Vaccines?CUSABIO Quarterly Citations Review: Q3 2024, Over 720 Citations with an Impact Factor Exceeding 3500, Totaling 23,600 Articles!ELISA vs. Multiplex Immunoassays: Why ELISA Remains the Gold Standard among ImmunoassaysCUSABIO Monthly Citations Review: In August, 240 High-Impact Citations, 23,400 Total Articles!Verified vs. Unverified Recombinant Proteins: Making the Right Choice for Your ResearchNectin-4 (NECTIN4): a Key Target in the IgSF Family, Boosting Clinical Drug Research in Various Tumors!CUSABIO Monthly Citations Review:240 High-Impact Citations, 23,200 Total Articles!CUSABIO Quarterly Citations Review: 800 High-Impact Citations, 23000 Total Articles!New Power in the Fight Against Cancer: Spotlight on Rising Stars of ADC Drugs at the 2024 ASCO Annual MeetingWhat Is Protein Characterization: Definition, Examples, Methods, and TechniquesWhat is Myc Tag: Definition, Function, Applications & Comparison with Other Epitope TagsWhat Are the Best Antibody Purification Methods for Your Research Needs?CT83/KK-LC-1: a Promising Therapeutic Target of CTAs Family, Currently in Clinical Research for Breast, Lung, Gastric Cancers, and Beyond!IL6: an Important Participant in the Inflammatory Cascade, One of the Most Functional Cytokines in Various Diseases Research!CUSABIO Quarterly Citations Review: 918 High-Impact Citations, Cumulative Impact Factor Exceeds 5000+!Interleukin 4 receptor (IL4R/IL4RA): a Multifunctional Target of Cytokines, Suggesting Diverse Potential in Asthma, Rhinitis, Viral, and Tumor Research!In Vivo vs. In Vitro: Choosing the Right Experimental Model for Your ResearchDipeptidase 3 (DPEP3): an Emerging Member of the DPEP Family, a Potential Therapeutic Target in Male Fertility or Tumor Research!CEACAM8: a Member of CEA Family, Emerging as a Vital Player in Gynaecological or Gastrointestinal Cancer Research!CD70 (CD27L/TNFSF7): a TNF Receptor Member, a “Star” Target for Clinical Research in Systemic Lupus Erythematosus (SLE), Arthritis, and Tumors!Serotransferrin/TF: a Major Transferrin in Plasma, a Novel TF-Modified Nanoparticle for Tumor-Targeting Research!Myosin Regulatory Light Chains (MYL12A and MYL12B): the New Functional Ligands for CD69, Potential Targets for Cardiac Disease or Tumors Research?CCR9: A Member of the Chemokine Receptor Family, an Emerging Target for Numerous Tumor Researches!Chemokine Receptor CCR6: the Specific Receptor for CCL20, a Potential Target for Drug Research in Inflammatory Diseases and Gastrointestinal Cancer!ACVRL1 (Alk1): a Member of the TGF-β Receptor Family, a Novel Target for Anti-Angiogenic Drug Research!Tetraspanin CD81: a Key Receptor for Hepatitis C Virus (HCV), an Established Exosome Marker, a Promising Target for Antiviral or Antitumor Research!TM4SF1: a Member of the Transmembrane-4-Superfamily (L6), a New Vascular Therapeutic Target?Anti-Payload Antibody DXD: A Highly Potent Tool for ADCs Pharmacokinetic (PK) Analysis!MAGEA4: a Member of the Melanoma-Associated Antigen (MAGE) Family, a Popular Target for Tumor-Specific Immune Research!CEACAM5: A Promising Member of CEACAM Family, A Potential Target for ADC Drug Research!CUSABIO Quarterly Literature Review: Over 1000 High Impact Factor Papers, Cumulative Impact Factor Surpasses 4000+!DSG3: An Emerging Tumor-Associated Adhesion Factor, a Specific Marker for the Clinical Diagnosis of Pemphigus Vulgaris (PV)!ENPP3 (CD203c): An Extracellular Enzyme, a Regulator for Nucleotide and Energy, an Indicator for Allergies, an Effective Target for RCC Therapy!Oncostatin M (OSM): A Member of IL-6 Cytokine Family, An Underestimated Player in Future Targeted Therapies?CDCP1: A Key Mediator for Cell Signaling in Cancers, an Emerging Target for Anti-Tumor Drugs!IL2RA (CD25): A Specific Marker of Tregs Functions as Both Immune Modulators and Targeted Agents in Various Diseases!BDCA2/CLEC4C: a Novel Plasma Cell-Like Dendritic Cell (pDC) Marker and Potent Inhibitor of IFN-I that Blocks SLE Development!GLP1R: An Energy Metabolism Regulator of GPCR Family, an Effective Drug Target for Type 2 Diabetes Therapy!DKK1: a Well-Characterized Wnt Inhibitor, a Multifunctional Regulator in Multiple Cancers!CEACAM6: a Potent CEA Family Molecule, a New Tumor Marker or Anti-Cancer Target!SIGIRR: A Novel Member of the TIR Superfamily Acts as the Anti-Inflammatory 'Brake' to Control Immune Response in Various Diseases!Microglial Markers: Insights into Microglial Activation and FunctionWhat Do You Need to Know Before Researching Human Metapneumovirus?Protein Phosphorylation: The Dynamic Language of Cellular RegulationCD69: a Classical Early Marker of Lymphocyte Activation, a Pivotal Regulator of Hematologic Diseases and Autoimmune Disorders!Discovery on TargetDSG2: a Vital Member of Desmosomal Cadherin Family, an Exciting New Target for Cardiomyopathy, Adenovirus, and Tumors!scholarshipULBP1: a Potent Member of NKG2D Ligands in CAR-T Therapy for Multiple Hematological and Solid Tumors!IL-17A: A Major Cytokine of the IL-17 Family, a Key Inflammation Target in Skin Diseases, or Inflammation-Associated Cancers!Great News! CUSABIO's Quarterly Citation: 455 Papers, 2356.7842 Impact Factor!Cadherin-17 (CDH17): A Viable Target in Bispecific Antibodies or CAR-T Therapy to Fight Many Gastrointestinal Cancers!CLDN3: Another Tight Junction Protein or New Drug Target, Interest in CLDN Family is Growing Fast!PROM1 (CD133): A New Cell Surface Marker of Cancer Stem Cells (CSCs), A More Significant Target for Immunotherapy!TPBG/5T4: the Oncofetal Protein, an Appealing Target for ADC or Vaccine Therapeutics in Tumors!Categories over 10000! --Rare diseases that are no longer Mucin-17/MUC17: An Unexpected Target for Tumor Immune Therapy, Notably Gastric Cancer!SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC!TMEFF2: a Tumor-Specific Methylated Biomarker, a Novel Target in Multiple CancersCD93, A Rising Star in Anti-Tumor TherapyNanoparticle platformProtein Tyrosine Kinases: Anti-tumor Targets to be Explored UrgentlySLC7A11: a New Potential Therapeutic Target via Induced Ferroptosis in Tumors!CLDN4: A Potential Prognostic Indicator and Therapeutic Target in Tumors！Intestinal Mucosal Barrier Bodyguard --ALPIHow did SARS-CoV-2 Variants get Names?ZG16B: A New Tumor Biomarker Offers Important Insights for Drug Development in Pancreatic Cancer!Proteolysis Targeting Chimera (PROTAC): A "Revolutionary" Technology in Small Molecule Drug Discovery!DDR1: a Novel Member of the RTKs Family, a Potential Target for Tumor Therapy!CLDN9: Another Key Regulator for Tumors or Hearing Loss from the CLDN Family!CLDN6: A "New Favorite" in Targeted Cancer Therapy after CLDN 18.2!Recombinant Monkeypox Virus Proteins - Accelerate Monkeypox ResearchSSTR2: A Prominent Target in SSTR Family, Offers a More Precise Therapy in Neuroendocrine Tumors (NET)GUCY2C: a Novel Target in Tumor Immunotherapy, Specially in Colorectal Cancer CAR T Therapy!ROR1, an Emerging Target for Tumor ImmunotherapyTTR: an Important Protein of Amyloidosis, Novel Therapies are Upcoming for Rare Diseases ATTR-CM and ATTR-PN!ANGPT2 (Ang-2): the First Bispecific Antibody for Eye Vision Loss Therapy, a Novel Target for Tumor Angiogenesis!GPRC5D: Newly Efficient GPRC5D CAR-T or Bispecific Antibody Therapy to Fight Multiple Myeloma (MM)CXCR4: An Attractive Target of GPCR family Brings Promising New Drugs for Cancer Therapy！Cellular Senescence and Its Markers2021 Insights on the CAR-T Cell Therapy: the Most Popular Targets for Solid Tumor!C5AR1: A Potential Molecule of Complement System to Fuel COVID-19 Therapy!CCR8: a Specific Marker on Tregs Cells, the Next Promising Candidate for Antitumor Drugs!GFRAL: A Promising Metabolic Target for Improving Obesity and Anorexia/CachexiaCross-reactivity of Antibody: Beneficial or Harmful?Agrimonia pilosa, Galla rhois, and APRG64, Which has the best antiviral activity against SARS-CoV-2?NKG2D (KLRK1), a Powerful Molecule Involved In CAR-T And Car-NK Cell TherapyDLL3: A New Molecular Target in CancerDoes Antibody-dependent Enhancement Occur in SARS-CoV-2 Infection?What Are Histones: Unraveling Their Critical Roles in Disease PathogenesisClaudin 18.2 (CLDN18): A 'Dark Horse' in Anti-tumour Therapy?GPC3: The Next-Promising Target in Cancer ImmunotherapyNeuronal Markers and Neurodegenerative DiseasesProtein Acetylation: An Important Post-translational Modification in Eukaryotic CellsA Group of Promising Proteins - Cell Cycle MarkersThe Oncogene HER2 (ERBB2): a New Target for Drug-Resistant TumorsNRG1: an Intriguing Therapeutic Target in DiseasesTNFR1 (TNFRSF1A): Elucidating Dual Mechanisms and Evolving as a Precision Therapeutic TargetMUC16 (CA125): a Promising Predictive Marker and Therapeutic Target in CancerERBB3/HER3: a New Target for Tumor Therapy, a Driver Gene of Multi-TumorsProteinase K and Its Market DevelopmentBladder Cancer: Insights into Molecular Biology,Signaling Pathways, and BiomarkersDecoding the Biological Complexity of Endometrial Cancer: Essential Insights for ResearchersOsteoprotegerin (OPG): What is Its Potential as a Biomarker or Therapeutic Target?Streptococcus pneumoniae, a Primary Cause of PneumoniaThe Multifunctional Enzyme CD38: A Target for Immunotherapeutic Approaches in CancerExploring Biological Landscape of Cervical Cancer: A Comprehensive Overview for ResearchersCD73 (NT5E), What a Powerful Therapy Target in Tumor ImmuneCD47, A New Target for Tumor ImmuneNew Mechanism, NRP1 Enhances the Ability of SARS-CoV-2 InfectionTMPRSS2, an Activator for SARS-CoV-2 InvasionCD147 (BSG), a New Target of SARS-CoV-2 InvasionACE2, The Hottest Target of SARS-CoV-2 InvasionHematopoietic Stem Cell Surface MarkerSurface Markers of Mesenchymal Stem Cells63.9% Objective Response Rate! B7-H3 (CD276) Targeted Therapy Transforms Small Cell Lung Cancer Treatment, Domestic Players Compete in Hundred-Billion-Yuan MarketSurface Markers of Natural Killer CellsGlial Fibrillary Acidic Protein - Astrocyte Specific MarkerCD146 (MCAM), A Powerful Tumor MarkerMesothelin (MSLN): A Rising Star of Cancer ImmunotherapyOMA1-A Potential Cancer Therapy TargetA Comprehensive Overview of Ovarian CancerTROP2 (TACSTD2), An Important Target for Cancer ResearchCD14, A Membrane Receptor for Bacterial LipopolysaccharidesCD19-The Most Popular Target with CAR T-Cell TherapyFocus on Emerging Therapeutic Targets BCMA (TNFRSF17)How can a zebrafish help solve the mystery of hereditary brain diseases?A unique retinal model reveals the genetic basis of macular degenerationSurface Markers That Help You Identify LymphocytesTET proteins regulate the factors necessary for normal antibody productionCAR-T Cell Therapy- An Useful Treatment To CancerWhat Are the Effects of Abnormalities in the ALK GeneResearchers have determined how liver cells can withstand virus attacksA healthy heart needs two proteins to work togetherNew potential therapeutic targets for pancreatic cancerNew strategies for targeting common cancersWhy are you drunk?Discovery of therapeutic targets for melanomaHow to Choose the Right Secondary Antibody?A newly found mouse model for the research of human gastric cancerDiscovery of potential new markers of invasive prostate cancerPrecisely targeted liposomes inhibit the metastasis of triple-negative breast cancer in miceCordycepin may provide new therapies for osteoarthritisThe discovery of mitochondrial to nuclear messenger proteinEnzyme USP15 regulates DNA homologous recombination repair and cancer cells response to PARP inhibitorsResearchers have developed a new molecule that can stop the progression of heart failureTag Antibodies, Your Good Partner in Protein ResearchA protein could be a boimaker in the blood test for early-stage liver disease Researchers have discovered the mechanism of how diabetes causes muscle lossTools You Need For Fundamental ResearchHow does sleep affect cardiovascular diseases?The unexpected discovery about rheumatoid arthritis offers a novel therapy for joint inflammationTCGA Database- A Good Partner of ResearchersWhat a Powerful Artifact of DNA Compression - HistoneThe Superb Journal CA(IF=244.59) Once Again Released an Article -Speed Reading on American Cancer DataIntroduction of Hepatocellular Carcinoma Related Signaling PathwaysWhat A Paradoxical TNF Signaling Pathway-Based on Different ReceptorsWhat Essential Biological Knowledge is Needed for Hepatocellular Carcinoma Research?CD Antigens - From Leucocytes Surface Markers to Diagnostic Markers for CancerWhat Are Immune Checkpoints?What Are Immune Checkpoint Inhibitors?What Are Immune Checkpoint Proteins?What Are Immune Checkpoint Pathways?A "trembling" Parkinson's DiseaseLatest neuroscience SCI impact factor summary in 2018Exploring Neurodegeneration: A Comprehensive Guide for ResearchersThe Overview of Breast Cancer: Related Signaling Pathways, Therapeutic TargetsHow to Choose an Antibody for Scientific Research?Technical ArticlesMyocardial InfarctionMolecular Weight CalculatorReconstitution / Molarity / Dilution CalculatorTumor markersBarbitone Sodium-Hydrochloric Acid Buffer solutionBarbitone Buffer solutionResearch ToolFAP may be a drug target for pancreatic cancerBulgariaHungaryHow to Choose the Right ELISA Kit for Your Research?ArgentinaSwimming??? Epstein-Barr Virus!!! NEDD8, An Important Target in Adipogenesis and Cancer TreatmentThe visit from Cedarlane labsDiabetes: What You Need to Know Before Starting Research?DenmarkArmeniaSaudi ArabiaThe visit from Group Research Tech. Inc. in TaiwanAll the staff gathered together to celebrate the fourth birthday of the company and to sing and dance for the coming New YearCusabio becomes a member of Hubei Pharmaceutical Industry AssociationThe visit from Cedarlane Labs in CanadaA visit from Salima in Saudi Arabia The Meaning of Irregular Antibody ScreeningThe difference between primary antibody and secondary antibodyArgoslab in Brazil took a visit to CUSABIOThe Secretary of the Party Working Committee of East Lake High-Tech Zone visited CUSABIOCUSABIO rewarded as the "2012 Gazelle Enterprise" of Wuhan East Lake High-tech ZoneCUSABIO held a patent knowledge training seminarThe general manager took part in the Warmly welcome Germany's Antibodies-online to CusabioCusabio provides volleyball clothing sponsorship for the Australian Life Research Pty LtdWarmly welcome the representatives of our Canadian distributor Cedarlane Laboratories Limited company to visit our companyWhat Are the Best Methods for Protein Purification? A Practical GuideMolecular Biology ServiceCUSABIO's Five Expression SystemsHow to express a protein with bioactivity?How to choose a suitable expression vector?How to Choose the Right Recombinant Protein for Your Experimental Model?How to Properly Reconstitute Lyophilized Proteins?Verified vs. Unverified Recombinant Proteins: Making the Right Choice for Your ResearchApproaches to Determinate Protein ConcentrationExploring Protein-Protein Interactions: A Comprehensive Guide to Understanding and Utilizing ItWhat Is Protein Characterization: Definition, Examples, Methods, and TechniquesProtein Tags: A Comprehensive Overview
Related pathways
Target Therapy
CUSABIO guaranteed quality
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of email
Email
support@cusabio.com
icon of address
Address
No. 269, Shendun 5th Road, Donghu Hi-Tech Development Area, Hubei Province, 430206, P.R.China
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Privacy Policy